Cargando…
Heterogeneity in M. tuberculosis β-lactamase inhibition by Sulbactam
For decades, researchers have elucidated essential enzymatic functions on the atomic length scale by tracing atomic positions in real-time. Our work builds on possibilities unleashed by mix-and-inject serial crystallography (MISC) at X-ray free electron laser facilities. In this approach, enzymatic...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485065/ https://www.ncbi.nlm.nih.gov/pubmed/37679343 http://dx.doi.org/10.1038/s41467-023-41246-1 |
_version_ | 1785102713831292928 |
---|---|
author | Malla, Tek Narsingh Zielinski, Kara Aldama, Luis Bajt, Sasa Feliz, Denisse Hayes, Brendon Hunter, Mark Kupitz, Christopher Lisova, Stella Knoska, Juraj Martin-Garcia, Jose Manuel Mariani, Valerio Pandey, Suraj Poudyal, Ishwor Sierra, Raymond G. Tolstikova, Alexandra Yefanov, Oleksandr Yoon, Chung Hong Ourmazd, Abbas Fromme, Petra Schwander, Peter Barty, Anton Chapman, Henry N. Stojkovic, Emina A. Batyuk, Alexander Boutet, Sébastien Phillips, George N. Pollack, Lois Schmidt, Marius |
author_facet | Malla, Tek Narsingh Zielinski, Kara Aldama, Luis Bajt, Sasa Feliz, Denisse Hayes, Brendon Hunter, Mark Kupitz, Christopher Lisova, Stella Knoska, Juraj Martin-Garcia, Jose Manuel Mariani, Valerio Pandey, Suraj Poudyal, Ishwor Sierra, Raymond G. Tolstikova, Alexandra Yefanov, Oleksandr Yoon, Chung Hong Ourmazd, Abbas Fromme, Petra Schwander, Peter Barty, Anton Chapman, Henry N. Stojkovic, Emina A. Batyuk, Alexander Boutet, Sébastien Phillips, George N. Pollack, Lois Schmidt, Marius |
author_sort | Malla, Tek Narsingh |
collection | PubMed |
description | For decades, researchers have elucidated essential enzymatic functions on the atomic length scale by tracing atomic positions in real-time. Our work builds on possibilities unleashed by mix-and-inject serial crystallography (MISC) at X-ray free electron laser facilities. In this approach, enzymatic reactions are triggered by mixing substrate or ligand solutions with enzyme microcrystals. Here, we report in atomic detail (between 2.2 and 2.7 Å resolution) by room-temperature, time-resolved crystallography with millisecond time-resolution (with timepoints between 3 ms and 700 ms) how the Mycobacterium tuberculosis enzyme BlaC is inhibited by sulbactam (SUB). Our results reveal ligand binding heterogeneity, ligand gating, cooperativity, induced fit, and conformational selection all from the same set of MISC data, detailing how SUB approaches the catalytic clefts and binds to the enzyme noncovalently before reacting to a trans-enamine. This was made possible in part by the application of singular value decomposition to the MISC data using a program that remains functional even if unit cell parameters change up to 3 Å during the reaction. |
format | Online Article Text |
id | pubmed-10485065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-104850652023-09-09 Heterogeneity in M. tuberculosis β-lactamase inhibition by Sulbactam Malla, Tek Narsingh Zielinski, Kara Aldama, Luis Bajt, Sasa Feliz, Denisse Hayes, Brendon Hunter, Mark Kupitz, Christopher Lisova, Stella Knoska, Juraj Martin-Garcia, Jose Manuel Mariani, Valerio Pandey, Suraj Poudyal, Ishwor Sierra, Raymond G. Tolstikova, Alexandra Yefanov, Oleksandr Yoon, Chung Hong Ourmazd, Abbas Fromme, Petra Schwander, Peter Barty, Anton Chapman, Henry N. Stojkovic, Emina A. Batyuk, Alexander Boutet, Sébastien Phillips, George N. Pollack, Lois Schmidt, Marius Nat Commun Article For decades, researchers have elucidated essential enzymatic functions on the atomic length scale by tracing atomic positions in real-time. Our work builds on possibilities unleashed by mix-and-inject serial crystallography (MISC) at X-ray free electron laser facilities. In this approach, enzymatic reactions are triggered by mixing substrate or ligand solutions with enzyme microcrystals. Here, we report in atomic detail (between 2.2 and 2.7 Å resolution) by room-temperature, time-resolved crystallography with millisecond time-resolution (with timepoints between 3 ms and 700 ms) how the Mycobacterium tuberculosis enzyme BlaC is inhibited by sulbactam (SUB). Our results reveal ligand binding heterogeneity, ligand gating, cooperativity, induced fit, and conformational selection all from the same set of MISC data, detailing how SUB approaches the catalytic clefts and binds to the enzyme noncovalently before reacting to a trans-enamine. This was made possible in part by the application of singular value decomposition to the MISC data using a program that remains functional even if unit cell parameters change up to 3 Å during the reaction. Nature Publishing Group UK 2023-09-07 /pmc/articles/PMC10485065/ /pubmed/37679343 http://dx.doi.org/10.1038/s41467-023-41246-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Malla, Tek Narsingh Zielinski, Kara Aldama, Luis Bajt, Sasa Feliz, Denisse Hayes, Brendon Hunter, Mark Kupitz, Christopher Lisova, Stella Knoska, Juraj Martin-Garcia, Jose Manuel Mariani, Valerio Pandey, Suraj Poudyal, Ishwor Sierra, Raymond G. Tolstikova, Alexandra Yefanov, Oleksandr Yoon, Chung Hong Ourmazd, Abbas Fromme, Petra Schwander, Peter Barty, Anton Chapman, Henry N. Stojkovic, Emina A. Batyuk, Alexander Boutet, Sébastien Phillips, George N. Pollack, Lois Schmidt, Marius Heterogeneity in M. tuberculosis β-lactamase inhibition by Sulbactam |
title | Heterogeneity in M. tuberculosis β-lactamase inhibition by Sulbactam |
title_full | Heterogeneity in M. tuberculosis β-lactamase inhibition by Sulbactam |
title_fullStr | Heterogeneity in M. tuberculosis β-lactamase inhibition by Sulbactam |
title_full_unstemmed | Heterogeneity in M. tuberculosis β-lactamase inhibition by Sulbactam |
title_short | Heterogeneity in M. tuberculosis β-lactamase inhibition by Sulbactam |
title_sort | heterogeneity in m. tuberculosis β-lactamase inhibition by sulbactam |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485065/ https://www.ncbi.nlm.nih.gov/pubmed/37679343 http://dx.doi.org/10.1038/s41467-023-41246-1 |
work_keys_str_mv | AT mallateknarsingh heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT zielinskikara heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT aldamaluis heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT bajtsasa heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT felizdenisse heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT hayesbrendon heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT huntermark heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT kupitzchristopher heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT lisovastella heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT knoskajuraj heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT martingarciajosemanuel heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT marianivalerio heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT pandeysuraj heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT poudyalishwor heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT sierraraymondg heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT tolstikovaalexandra heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT yefanovoleksandr heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT yoonchunghong heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT ourmazdabbas heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT frommepetra heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT schwanderpeter heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT bartyanton heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT chapmanhenryn heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT stojkoviceminaa heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT batyukalexander heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT boutetsebastien heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT phillipsgeorgen heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT pollacklois heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam AT schmidtmarius heterogeneityinmtuberculosisblactamaseinhibitionbysulbactam |